Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Change in Acquisitions & Divestments (2016 - 2025)

ImmunityBio (IBRX) has disclosed Change in Acquisitions & Divestments for 11 consecutive years, with $59.5 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 230.19% to $59.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.9 million through Dec 2025, down 43.85% year-over-year, with the annual reading at $64.9 million for FY2025, 43.85% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $59.5 million at ImmunityBio, up from $5.4 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $113.4 million in Q2 2022, with the low at -$31.0 million in Q4 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $22.2 million, with a median of $10.1 million recorded in 2023.
  • Peak annual rise in Change in Acquisitions & Divestments hit 12665.69% in 2024, while the deepest fall reached 11703.92% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at -$31.0 million in 2021, then soared by 147.6% to $14.8 million in 2022, then crashed by 31.54% to $10.1 million in 2023, then soared by 78.55% to $18.0 million in 2024, then skyrocketed by 230.19% to $59.5 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $59.5 million, $5.4 million, and $18.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.